The serum levels of adiponectin were also significantly negatively correlated with the serum levels of free cholesterol (IDL-FC) and triglycerides (IDL-TG) in intermediate-density lipoprotein (IDL) in HVs but, again, not in patients with MS (Table 4). This evidence concerns the gene ADIPOQ and myeloid sarcoma.